Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Brimonidine Tartrate (AGN190342 tartrate) is a quinoxaline derivative and adrenergic α-2 receptor agonist (EC50: 0.45 nM) that is used to manage intraocular pressure associated with open-angle glaucoma or ocular hypertension.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | In stock | $ 41.00 | |
500 mg | In stock | $ 126.00 |
Description | Brimonidine Tartrate (AGN190342 tartrate) is a quinoxaline derivative and adrenergic α-2 receptor agonist (EC50: 0.45 nM) that is used to manage intraocular pressure associated with open-angle glaucoma or ocular hypertension. |
Targets&IC50 | α2A-adrenoceptor:0.45 nM(EC50) |
Synonyms | AGN190342 tartrate, 304 tartrate, AGN190342 (tartrate), UK 14304 (tartrate), UK14304 tartrate |
Molecular Weight | 442.22 |
Formula | C15H16BrN5O6 |
CAS No. | 70359-46-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 199 mM
H2O: 56.53mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Brimonidine Tartrate 70359-46-5 GPCR/G Protein Neuroscience Adrenergic Receptor AGN190342 AGN-190342 Brimonidine AGN 190342 Tartrate AGN190342 tartrate UK 14304 Inhibitor 304 tartrate Beta Receptor UK14304 UK 14304 Tartrate UK-14304 AGN 190342 AGN-190342 Tartrate inhibit 304 Tartrate AGN190342 (tartrate) AGN190342 Tartrate UK 14304 (tartrate) UK14304 tartrate UK14304 Tartrate UK-14304 Tartrate inhibitor